EA200000973A1 - Желудочная и/или дуоденальная клейкая фармацевтическая композиция - Google Patents

Желудочная и/или дуоденальная клейкая фармацевтическая композиция

Info

Publication number
EA200000973A1
EA200000973A1 EA200000973A EA200000973A EA200000973A1 EA 200000973 A1 EA200000973 A1 EA 200000973A1 EA 200000973 A EA200000973 A EA 200000973A EA 200000973 A EA200000973 A EA 200000973A EA 200000973 A1 EA200000973 A1 EA 200000973A1
Authority
EA
Eurasian Patent Office
Prior art keywords
mucous membrane
drug
duodenal
gastric
pharmaceutical composition
Prior art date
Application number
EA200000973A
Other languages
English (en)
Other versions
EA003512B1 (ru
Inventor
Тосио Инаги
Хироюки Сираи
Нориказу Ямагути
Такеси Нисино
Original Assignee
Кова Ко., Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP10072099A external-priority patent/JPH11269064A/ja
Application filed by Кова Ко., Лтд. filed Critical Кова Ко., Лтд.
Publication of EA200000973A1 publication Critical patent/EA200000973A1/ru
Publication of EA003512B1 publication Critical patent/EA003512B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Adhesives Or Adhesive Processes (AREA)

Abstract

Настоящее изобретение обеспечивает желудочную и/или дуоденальную клейкую фармацевтическую композицию, получаемую путем нанесения на композицию, которая включает лекарственное средство, действующее в желудке и/или двенадцатиперстной кишке, и один или более ингредиентов, выбранных из водонерастворимых полимеров, полиглицериновых эфиров жирных кислот, липидов и восков, покрытия из полимера, обладающего в кислых условиях адгезионной способностью относительно поверхности слизистой оболочки пищеварительного тракта, а в нейтральных или щелочных условиях отделяющегося от слизистой оболочки пищеварительного тракта. Эта композиция прилипает только к слизистой оболочке желудка и/или двенадцатиперстной кишки и выделяет лекарственное средство в течение длительного времени, таким образом, что, используя небольшое количество лекарственного средства, достигают достаточных эффектов.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200000973A 1998-03-20 1999-03-17 Желудочная и/или дуоденальная клейкая лекарственная форма EA003512B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP7209898 1998-03-20
JP10072099A JPH11269064A (ja) 1998-03-20 1998-03-20 胃・十二指腸付着性医薬組成物
PCT/JP1999/001311 WO1999048532A1 (fr) 1998-03-20 1999-03-17 Compositions medicinales adherant a l'estomac/au duodenum

Publications (2)

Publication Number Publication Date
EA200000973A1 true EA200000973A1 (ru) 2001-02-26
EA003512B1 EA003512B1 (ru) 2003-06-26

Family

ID=26413237

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200000973A EA003512B1 (ru) 1998-03-20 1999-03-17 Желудочная и/или дуоденальная клейкая лекарственная форма

Country Status (17)

Country Link
US (1) US6582720B1 (ru)
EP (1) EP1062955A1 (ru)
KR (1) KR20010041019A (ru)
CN (1) CN1293576A (ru)
AU (1) AU748299B2 (ru)
BR (1) BR9908616A (ru)
CA (1) CA2320387A1 (ru)
EA (1) EA003512B1 (ru)
HU (1) HUP0101248A2 (ru)
ID (1) ID26247A (ru)
MY (1) MY120798A (ru)
NO (1) NO20004049L (ru)
NZ (1) NZ506280A (ru)
PL (1) PL342971A1 (ru)
TR (1) TR200002465T2 (ru)
TW (1) TW585770B (ru)
YU (1) YU51300A (ru)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU775995B2 (en) * 1999-06-07 2004-08-19 Nycomed Gmbh Novel preparation and administration form comprising an acid-labile active compound
US8101209B2 (en) 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
IL164221A0 (en) 2002-04-09 2005-12-18 Flamel Tech Sa Oral pharmaceutical formulation in the form of aqueous suspension of microcapsules for modified release of amoxicillim
CA2480826C (fr) 2002-04-09 2012-02-07 Flamel Technologies Formulation pharmaceutique orale sous forme de suspension aqueuse de microcapsules permettant la liberation modifiee de principe(s) actif(s)
US7670627B2 (en) * 2002-12-09 2010-03-02 Salvona Ip Llc pH triggered targeted controlled release systems for the delivery of pharmaceutical active ingredients
US20050281795A1 (en) * 2004-06-17 2005-12-22 Amano Enzyme Usa., Ltd. And Amano Enzyme,Inc. Controlled release formulations of enzymes, microorganisms, and antibodies with mucoadhesive polymers
US8252333B2 (en) 2006-01-26 2012-08-28 Jorge Cueto-Garcia Biodegradable, non-toxic biological adhesive for use in abdominal surgery
WO2007086078A2 (en) * 2006-01-30 2007-08-02 Panacea Biotec Ltd. Novel pharmaceutical compositions and process of preparation thereof
US20080279921A1 (en) * 2007-05-07 2008-11-13 Ceramoptec Industries, Inc. Gel-formulations of hydrophobic photosensitizers for mucosal applications
US20090105561A1 (en) * 2007-10-17 2009-04-23 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Medical or veterinary digestive tract utilization systems and methods
US8303573B2 (en) 2007-10-17 2012-11-06 The Invention Science Fund I, Llc Medical or veterinary digestive tract utilization systems and methods
US8707964B2 (en) * 2007-10-31 2014-04-29 The Invention Science Fund I, Llc Medical or veterinary digestive tract utilization systems and methods
US8789536B2 (en) 2007-10-17 2014-07-29 The Invention Science Fund I, Llc Medical or veterinary digestive tract utilization systems and methods
US8808276B2 (en) * 2007-10-23 2014-08-19 The Invention Science Fund I, Llc Adaptive dispensation in a digestive tract
US8109920B2 (en) * 2007-10-31 2012-02-07 The Invention Science Fund I, Llc Medical or veterinary digestive tract utilization systems and methods
US8333754B2 (en) * 2007-10-31 2012-12-18 The Invention Science Fund I, Llc Medical or veterinary digestive tract utilization systems and methods
US8808271B2 (en) * 2007-10-31 2014-08-19 The Invention Science Fund I, Llc Medical or veterinary digestive tract utilization systems and methods
US20090163894A1 (en) * 2007-10-31 2009-06-25 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Medical or veterinary digestive tract utilization systems and methods
US20090137866A1 (en) * 2007-11-28 2009-05-28 Searete Llc, A Limited Liability Corporation Of The State Delaware Medical or veterinary digestive tract utilization systems and methods
EP2255794A1 (en) * 2009-05-29 2010-12-01 H e x a l Aktiengesellschaft Enteric coating
CA2774951C (en) 2009-09-24 2014-12-16 Allergan, Inc. Method of treating osteoporosis with a neurotoxin

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5846019A (ja) * 1981-09-14 1983-03-17 Kanebo Ltd 持続性ニフエジピン製剤
DE4036757A1 (de) * 1990-11-17 1992-05-21 Bayer Ag Antazida-zubereitung mit verlaengerter magenverweilzeit
TW209174B (ru) 1991-04-19 1993-07-11 Takeda Pharm Industry Co Ltd
EP0642797B1 (en) 1993-09-09 2000-05-17 Takeda Chemical Industries, Ltd. Formulation comprising antibacterial substance and antiulcer substance
WO1995026715A2 (en) * 1994-03-30 1995-10-12 Dumex-Alpharma A/S Use of fatty acid esters as bioadhesive substances
JPH09104640A (ja) 1995-08-04 1997-04-22 Takeda Chem Ind Ltd 胃粘膜付着性組成物
EP0867191A4 (en) * 1995-11-27 2000-01-05 Yamanouchi Pharma Co Ltd MEDICINE COMPOSITION
JPH10167985A (ja) 1996-10-08 1998-06-23 Takeda Chem Ind Ltd 抗ヘリコバクター剤
CN1251035A (zh) 1997-03-25 2000-04-19 武田药品工业株式会社 胃肠粘膜粘附性药物组合物

Also Published As

Publication number Publication date
CN1293576A (zh) 2001-05-02
TR200002465T2 (tr) 2000-12-21
KR20010041019A (ko) 2001-05-15
YU51300A (sh) 2002-09-19
MY120798A (en) 2005-11-30
NZ506280A (en) 2001-08-31
AU748299B2 (en) 2002-05-30
AU2852499A (en) 1999-10-18
NO20004049L (no) 2000-10-03
EA003512B1 (ru) 2003-06-26
US6582720B1 (en) 2003-06-24
HUP0101248A2 (hu) 2001-08-28
NO20004049D0 (no) 2000-08-11
CA2320387A1 (en) 1999-09-30
ID26247A (id) 2000-12-07
PL342971A1 (en) 2001-07-16
BR9908616A (pt) 2000-10-31
TW585770B (en) 2004-05-01
EP1062955A1 (en) 2000-12-27

Similar Documents

Publication Publication Date Title
EA200000973A1 (ru) Желудочная и/или дуоденальная клейкая фармацевтическая композиция
DE69704014D1 (de) Verfahren zur Herstellung von konjugierter Linolsäure
DE58905425D1 (de) Verfahren zur Herstellung phosphorhaltiger L-Aminosäuren sowie ihrer Ester und N-Derivate.
DE69922309D1 (de) Verfahren zur Herstellung von Fettsäureestern
DE69736699D1 (de) Verfahren zur Herstellung von L-Lysin
DE69727260D1 (de) Verfahren zur Herstellung von L-Lysin
DE69736698D1 (de) Verfahren zur Herstellung von L-Lysin
DE69212879D1 (de) Magensaftstabile pharmazeutische Formulierungen zur Oral Verbreichung von Gallensäuren
DE69015591D1 (de) Verfahren zur Herstellung von Estern von ungesättigten Carbonsäuren.
CA2335769A1 (en) Aqueous extraction process to selectively remove phospholipid from egg yolks
DE59812758D1 (de) Verfahren zur herstellung von 8-methoxy-chinoloncarbonsäuren
EP0803199A3 (en) Procedure and fodder for the production of hen's eggs having an advantageous fatty acid composition
DE59104023D1 (de) Verfahren zur Herstellung von monoethylenisch ungesättigten Carbonsäureestern.
DE60205955D1 (de) Verfahren zur Herstellung von L-Aminosäuren
EP1080724A4 (en) COMPOSITIONS FOR REDUCING MTP ACTIVITY
DE59810616D1 (de) Verfahren zur Herstellung von Saccharosefettsäureestern
DE69920568D1 (de) Verfahren zur Herstellung von optisch aktivem 4-Halo-3-hydroxybuttersäureester
DE69706622D1 (de) Verfahren zur Herstellung von Hydroxybenzoesäuren
DE69016065D1 (de) Verfahren zur Herstellung von Calciumsalzen von Fettsäuren.
DE68913342D1 (de) Verfahren zur Herstellung von Carbonsäureestern.
DE69621376D1 (de) Verfahren zur Herstellung von Citrakonsäureanhydrid
DE60123564D1 (de) Verfahren zur Herstellung von Estern ungesättigter Carbonsäuren
DE69204626D1 (de) Verfahren zur Herstellung von Estern aus Aminosäuren.
DE60043610D1 (de) Verfahren zur herstellung von l-lysin
CA2293367A1 (en) Wax esters enriched in .omega.-3 unsaturated fatty acids, their preparation and their use

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU